AstraZeneca : Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit	18-10-15	RE
Sanofi : sees new acquisitions and drugs reviving growth	18-04-27	RE
Blackstone LP : Sanofi in talks to sell generics arm to Advent for 1.9 billion euros	18-04-17	RE
Takeda Pharmaceutical : Merits of any Takeda bid for Shire questioned, shares slide	18-03-29	RE
Takeda Pharmaceutical : Merits of any Takeda bid for Shire questioned, shares slide	18-03-29	RE
Takeda Pharmaceutical : Drugmaker Shire soars as Japan's Takeda considers bid	18-03-28	RE
Ablynx : Drugmaker Novo Nordisk looks to former oil boss to energise M&A	18-03-22	RE
Ablynx : Sanofi's return to profit growth this year slower than hoped	18-02-07	RE
Ablynx : Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom	18-01-29	RE
Ablynx : Chipmakers, Sanofi deal dominate European share trading	18-01-29	RE
Ablynx : Novo Nordisk remains on hunt for biopharma deals	18-01-29	RE
Ablynx : Biotech M&A takes off as Sanofi and Celgene spend $20 billion	18-01-22	RE
Biogen : Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion	18-01-22	RE
Bioverativ : New drugs recast $10 billion haemophilia market as Sanofi swoops in	18-01-22	RE
Associated British Foods : European shares edge higher as cyclicals back in favour	18-01-18	RE

Analyst Recommendations on Ablynx

Associated British Foods : European shares edge higher as cyclicals back in favour	18-01-18	RE
Ablynx : Bond sell-off hits European shares but boost banks	18-01-10	RE

Immunicum : and DCprime Combine Forces to Establish Leader in Cell-Based Cancer Immunotherapies	20-11-19	AQ
Ablynx : SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE	18-06-19	GL
Ablynx : PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")	18-05-28	GL
Ablynx : PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")	18-05-28	GL
Ablynx : NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020	18-05-25	GL

News in other languages on Ablynx

SANOFI : a finalisé l'acquisition d'Ablynx	18-06-19
Les marchés européens marquent une pause, scrutent la politique italienne	18-05-14
Sanofi : A suivre aujourd'hui	18-05-14
SANOFI : détient 95,60% des actions d'ABLYNX	18-05-14
Sanofi : L'offre publique d'achat de Sanofi sur Ablynx débutera le 4 avril	18-03-29

Managers	Title	Age	Since
Petrus Houwen CEO	Chief Executive Officer	-	19-03-31

Members of the board	Title	Age	Since
Kristine de Sutter BRD	Director/Board Member	-	19-03-31
Pieter Oldenziel BRD	Director/Board Member	-	18-12-31

Sector

	1st Jan change	Capi.
MODERNA, INC.	+29.03%	48.16B
IQVIA HOLDINGS INC.	-0.10%	41.73B
LONZA GROUP AG	+43.45%	41.03B
CELLTRION, INC.	-5.26%	28.77B
ICON PUBLIC LIMITED COMPANY	+11.48%	25.59B
ALNYLAM PHARMACEUTICALS, INC.	-22.74%	18.96B
BIO-TECHNE CORPORATION	+9.06%	12.92B
MEDPACE HOLDINGS, INC.	+30.01%	12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.51%	11.77B